BSTG
Price:
$4.03
Market Cap:
$57.82M
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
Industry
Biotechnology
IPO Date
2013-10-21
Stock Exchange
OTC
Ticker
BSTG
According to Biostage, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.91. This represents a change of -60.50% compared to the average of 2.30 of the last 4 quarters.
The mean historical Current Ratio of Biostage, Inc. over the last ten years is 2.81. The current 0.91 Current Ratio has changed 3.13% with respect to the historical average. Over the past ten years (40 quarters), BSTG's Current Ratio was at its highest in in the September 2015 quarter at 25.63. The Current Ratio was at its lowest in in the December 2023 quarter at 0.
Average
2.81
Median
1.97
Minimum
0
Maximum
12.19
Discovering the peaks and valleys of Biostage, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 12.19
Minimum Annual Increase = -100.00%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 3.17 | Infinity% |
| 2023 | 0 | -100.00% |
| 2022 | 1.17 | 194.18% |
| 2021 | 0.40 | -82.08% |
| 2020 | 2.22 | 28.33% |
| 2019 | 1.73 | -46.88% |
| 2018 | 3.25 | 19.59% |
| 2017 | 2.72 | 116.74% |
| 2016 | 1.26 | -89.70% |
| 2015 | 12.19 | 48.44% |
The current Current Ratio of Biostage, Inc. (BSTG) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.45
5-year avg
1.39
10-year avg
2.81
Biostage, Inc.’s Current Ratio is less than Herantis Pharma Oyj (8.10), less than Oncopeptides AB (publ) (3.42), less than Mindset Pharma Inc. (1.18), less than Karolinska Development AB (publ) (7.99), less than Medivir AB (publ) (4.39), less than Abliva AB (publ) (4.13), less than E-therapeutics Plc (8.87), less than Relief Therapeutics Holding AG (4.05), less than Goodness Growth Holdings, Inc. (1.28), less than MCI Onehealth Technologies Inc. (0),
| Company | Current Ratio | Market cap |
|---|---|---|
| 8.10 | $59.47M | |
| 3.42 | $55.98M | |
| 1.18 | $54.51M | |
| 7.99 | $68.85M | |
| 4.39 | $45.78M | |
| 4.13 | $45.13M | |
| 8.87 | $75.96M | |
| 4.05 | $44.94M | |
| 1.28 | $61.05M | |
| 0 | $54.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biostage, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biostage, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Biostage, Inc.'s Current Ratio?
How is the Current Ratio calculated for Biostage, Inc. (BSTG)?
What is the highest Current Ratio for Biostage, Inc. (BSTG)?
What is the 3-year average Current Ratio for Biostage, Inc. (BSTG)?
What is the 5-year average Current Ratio for Biostage, Inc. (BSTG)?
How does the current Current Ratio for Biostage, Inc. (BSTG) compare to its historical average?